Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
275,000,000
-
Total 13F shares
-
17,998,551
-
Share change
-
+1,097,379
-
Total reported value
-
$475,216,635
-
Price per share
-
$26.54
-
Number of holders
-
51
-
Value change
-
+$32,037,839
-
Number of buys
-
31
-
Number of sells
-
28
Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q4 2020
As of 31 Dec 2020,
Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,998,551 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, Artal Group S.A., SANDS CAPITAL MANAGEMENT, LLC, Casdin Capital, LLC, FRANKLIN RESOURCES INC, Alphabet Inc., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, and PERCEPTIVE ADVISORS LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.